| Cell line name | Hepa-SC | |
|---|---|---|
| Synonyms | HepaSC | |
| Accession | CVCL_FA14 | |
| Resource Identification Initiative | To cite this cell line use: Hepa-SC (RRID:CVCL_FA14) | |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4980. Characteristics: Has stem-like cell properties. Can be differentiated/reprogrammed using mechanical stress and in the presence of at least one differentiation factor. Derived from site: In situ; Liver; UBERON=UBERON_0002107. | |
| Disease | Hepatitis C infection (NCIt: C3098) Hepatocellular carcinoma (NCIt: C3099) Hepatocellular carcinoma (ORDO: Orphanet_88673) | |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
| Hierarchy | Parent: CVCL_9720 (HepaRG) Children:
| |
| Sex of cell | Female | |
| Age at sampling | Age unspecified | |
| Category | Cancer cell line | |
| Publications | Patent=US20160168536 | |
| Cross-references | ||
| Encyclopedic resources | Wikidata; Q54882817 | |
| Entry history | ||
| Entry creation | 26-Sep-2016 | |
| Last entry update | 29-Jun-2023 | |
| Version number | 10 | |